NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3X ETF (LABD) Price, Holdings, & News $7.95 +0.70 (+9.60%) As of 02:26 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsOwnership About Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LABD alerts:Sign Up Key Stats Today's Range$7.11▼$8.1650-Day Range$5.90▼$9.3452-Week Range$5.81▼$37.74Volume23.58 million shsAverage Volume9.51 million shsMarket Capitalization$156.22 millionAssets Under Management$130.20 millionDividend Yield5.79%Net Expense Ratio1.07%Aggregate RatingN/A ETF Overview The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bear 3X ETF ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.55%0.57%0.50%0.53%Other Expenses0.33%0.52%0.53%0.60%0.54%Total Expense1.08%0.76%0.75%0.75%0.73%Fee Waiver-0.01%-0.85%-0.67%-0.78%-0.68%Net Expense1.07%0.58%0.63%0.57%0.60% Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3X ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABD ETF News HeadlinesStock Traders Purchase Large Volume of Direxion Daily S&P Biotech Bear 3X ETF Put Options (NYSEARCA:LABD)October 5 at 11:01 AM | americanbankingnews.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0707September 22, 2026 | msn.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.October 6 at 1:00 AM | InvestorPlace (Ad)Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0707September 22, 2026 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0752June 23, 2026 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0853March 26, 2026 | msn.comSee More Headlines LABD ETF - Frequently Asked Questions How have LABD shares performed this year? Direxion Daily S&P Biotech Bear 3X ETF's stock was trading at $21.06 on January 1st, 2026. Since then, LABD stock has decreased by 61.4% and is now trading at $8.1250. When did Direxion Daily S&P Biotech Bear 3X ETF's stock split? Direxion Daily S&P Biotech Bear 3X ETF shares reverse split on Friday, August 28th 2020.The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Direxion Daily S&P Biotech Bear 3X ETF? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3X ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3X ETF investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3X ETF (LABU), NVIDIA (NVDA) and Intel (INTC). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3X ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings23 Fund Statistics Assets Under Management$130.20 million Average Daily Volume$22.09 million Discount/Premium0.00% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume4,555 Put Options3,889 Call Options666 Short Interest2,490,000 shs Miscellaneous Outstanding Shares19,660,000Beta-2.43 Creation Unit50,000 Creation Fee$250.00 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report Top 10 LABD HoldingsGOLDMAN FINL SQ TRSRY INST 506Holding Weight: 34.94%DREYFUS GOVT CASH MAN INSHolding Weight: 33.48%GOLDMAN SACHS FIN GOV 465 INSTITUTHolding Weight: 23.30%DREYFUS TRSRY SECURITIES CASH MGMTHolding Weight: 2.25%SPSIBI SWAP ASSET LEGHolding Weight: -3.01%SPSIBI SWAP ASSET LEGHolding Weight: -4.08%SPSIBI SWAP ASSET LEGHolding Weight: -11.32%SPSIBI SWAP ASSET LEGHolding Weight: -59.09%SPSIBI SWAP ASSET LEGHolding Weight: -104.53%SPSIBI SWAP ASSET LEGHolding Weight: -117.97%Full Holdings Details This page (NYSEARCA:LABD) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersNvidia’s record quarter could send this new type of AI soaringNvidia just posted 96.2 billion in revenue for a single quarter, more than Coca-Cola generates in an entire ye...Brownstone Research | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredThis smart glasses tech is bringing the screen to your eyesGlobal AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...The Tomorrow Investor | SponsoredThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...Stansberry Research | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3X ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3X ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABD Stock Alerts